GERMANTOWN, Md., April 16, 2014 /PRNewswire/ -- Intrexon
Corporation (NYSE: XON), a leader in synthetic biology, today
announced the appointment of James S.
Turley to its Board of Directors, effective April 16. Mr. Turley will occupy the board seat
vacated by Thomas Reed, Ph.D.,
Founder and Chief Science Officer of Intrexon. Dr. Reed will
continue to serve as Chief Science Officer.
Mr. Turley is the former Chairman and Chief Executive Officer of
Ernst & Young. He led the firm from 2001 until his
retirement in June of 2013. Mr. Turley joined Ernst &
Young in 1977 and held various positions there until being named
Regional Managing Partner for the Upper Midwest in 1994, and for
New York in 1998. He was
named Deputy Chairman in 2000 and Chairman in 2001.
Mr. Turley holds an undergraduate degree and a master's in
accounting from Rice University. He serves on the Board
of Directors of the Boy Scouts of America, Board of Trustees for
Rice University, and is chair of the
National Corporate Theatre Fund. He also serves on the
Committee for Economic Development. He was on the board of
Catalyst from 2001-2013, serving as its Chair from 2009-2013, and
until his retirement was a member of the Business Roundtable and
IBLAC (International Business Leaders Advisory Council for the
Mayor of Shanghai), and was
co-chair of Russia's Foreign
Investment Advisory Council. He also chaired the Governing
Board of the U.S. Center for Audit Quality from 2007-2011.
Mr. Turley currently serves on the corporate boards for Citigroup
and Emerson Electric Company.
Dr. Reed commented on his continued commitment to Intrexon's
growth and Mr. Turley's addition to the Intrexon team. "While
my fulltime attention has always been and shall remain focused on
the success of Intrexon, I believe that relinquishing my Board seat
in favor of an outstanding independent director is in keeping with
that focus and is consistent with the best practices of corporate
governance. I feel very confident that Jim Turley will serve Intrexon well on our
Board."
On Mr. Turley's joining the Board, Randal J. Kirk, Chairman and Chief Executive
Officer of Intrexon, observed, "Jim is a highly respected business
professional with an impressive track record, having led Ernst
& Young during some challenging economic times. His
effective direction of a global organization instilled the trust
and confidence of key stakeholders and is a testament to his
ability to deliver results within a team. We all look forward
to working with Jim and enjoying his guidance and stewardship on
our Board of Directors."
Mr. Turley added, "Intrexon is applying their synthetic biology
capabilities across a wide array of applications in areas of unmet
need, from novel therapeutics to alternative fuel production.
The potential of their technology platforms to meet the challenges
of a growing population with growing needs is vast. I am
excited to join the Board and embark on Intrexon's journey toward
improving the quality of life and health of the planet."
About Intrexon Corporation
Intrexon
Corporation (NYSE: XON) is a leader in synthetic biology
focused on collaborating with companies in Health, Food, Energy,
Environment, and Consumer Sectors to create biologically-based
products that improve the quality of life and the health of the
planet. Through the company's proprietary UltraVector®
platform, Intrexon provides its partners with
industrial-scale design and development of complex biological
systems. The UltraVector® platform delivers unprecedented
control over the quality, function, and performance of living
cells. We call our synthetic biology approach and integrated
technologies Better DNA®, and we invite you to discover more at
www.dna.com.
Safe Harbor Statement
Some of the statements made in
this press release are forward-looking statements. These
forward-looking statements are based upon our current expectations
and projections about future events and generally relate to our
plans, objectives and expectations for the development of our
business. Although management believes that the plans and
objectives reflected in or suggested by these forward-looking
statements are reasonable, all forward-looking statements involve
risks and uncertainties and actual future results may be materially
different from the plans, objectives and expectations expressed in
this press release.
Intrexon Corporate Contact
Marie L. Rossi, Ph.D.
Senior Manager, Technical Communications
Tel. +1 (301) 556-9944
Email: PublicRelations@intrexon.com
Logo -
http://photos.prnewswire.com/prnh/20130919/NY83283LOGO
SOURCE Intrexon Corporation